Guinea vs Timor-Leste: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Guinea
2.8%
in 2024
Timor-Leste
1.0%
in 2024
Guinea rank
6th
Timor-Leste rank
3rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Guinea
- Timor-Leste
How they compare
Guinea currently reports 2.8% against 1.0% in Timor-Leste, a difference of 1.8%.
That makes Guinea's figure about 2.8 times Timor-Leste's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Timor-Leste ahead.
Guinea ranks 6th and Timor-Leste ranks 3rd of 215 countries.
Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 2.5% | 0.3% | Guinea |
| 2020s | 2.7% | 1.3% | 1.4% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Guinea or Timor-Leste?
- Guinea, at 2.8% against 1.0% in Timor-Leste as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Guinea and Timor-Leste?
- 1.8%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Timor-Leste?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea and Timor-Leste rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Guinea ranks 6th and Timor-Leste ranks 3rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.